Diana Harshbarger: “When someone is fighting for their life, the last thing they need is the government standing in their way.”

The 340B program was created with good intentions to help vulnerable and underserved patients access care, but unfortunately, it has evolved into a massive, poorly supervised program with weak transparency and accountability safeguards.

Thank you, Ranking Member Pallone. Mr. Speaker, I yield to the gentleman from Ohio (Mr. Balderson).

As a pharmacist for more than 30 years, I’ve seen how government-protected monopolies can drive up costs, stifle innovation, and ultimately leave patients paying the price.

As a lifelong pharmacist, I’ve seen firsthand how PBMs game the system. When the same corporate giant that sets reimbursement rates also owns the pharmacy collecting them, that’s not a free market—it’s a rigged one.